First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer

Julien Peron 1 O. Tredan Isabelle Ray-Coquard Thomas Bachelot S. I. Labidi Galy B. Favier I. Treilleux J. P. Guastalla
1 Biostatistiques santé
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
Document type :
Journal articles
Complete list of metadatas
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02282750
Contributor : Marie-Gabrielle Chautard <>
Submitted on : Tuesday, September 10, 2019 - 11:23:43 AM
Last modification on : Monday, February 10, 2020 - 4:36:57 PM

Identifiers

Collections

UNIV-LYON1 | CNRS | BIOENVIS | INRIA | UDL

Citation

Julien Peron, O. Tredan, Isabelle Ray-Coquard, Thomas Bachelot, S. I. Labidi Galy, et al.. First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer. Bulletin du cancer, 2012, 99, pp.E18-25. ⟨10.1684/bdc.2011.1537⟩. ⟨hal-02282750⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

12

Contact

Informations

CCSD